SI-BONE, Inc. (SIBN) has received FDA 510(k) clearance for its iFuse TORQ TNT implant system, designed for the specific anatomical needs of pelvic fragility fractures. This innovative system promises to be more effective than current treatments like cannulated screws, offering early fixation, reduced screw backout, and faster patient recovery. The news highlights SI-BONE’s commitment to developing solutions for unmet clinical needs in the growing sacroiliac joint fusion market.